Peptide Doctors in La Jolla

BPC-157 is a synthetic pentadecapeptide. See the TruthTides evidence library for graded study summaries, regulatory status, and citations.

Thymosin Alpha-1 is a naturally occurring thymic peptide. See the TruthTides evidence and regulatory libraries for graded study summaries, approval status, and citations.

Ipamorelin is a selective growth hormone secretagogue. See the TruthTides evidence library for graded study summaries and citations.

CJC-1295 is a synthetic GHRH analog. See the TruthTides evidence library for graded study summaries, pharmacokinetic data, and citations.

Semaglutide is a GLP-1 receptor agonist FDA-approved for type 2 diabetes (Ozempic) and chronic weight management (Wegovy). Clinical trials demonstrate significant reductions in body weight and cardiovascular risk markers. It works by enhancing insulin secretion, suppressing glucagon, and reducing appetite.

Tirzepatide is a dual GIP/GLP-1 receptor agonist FDA-approved for type 2 diabetes (Mounjaro) and weight management (Zepbound). It has shown superior weight loss outcomes compared to semaglutide in head-to-head trials. The dual-agonist mechanism provides enhanced metabolic benefits.

Tesamorelin is an FDA-approved synthetic GHRH analog indicated for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. It stimulates physiological growth hormone secretion and has demonstrated significant visceral adipose tissue reduction in clinical trials.

Sermorelin is a synthetic analog of the first 29 amino acids of GHRH, previously FDA-approved for growth hormone deficiency diagnosis and treatment. It stimulates natural GH production from the pituitary gland and is widely used in age-management protocols for its favorable safety profile.

PT-141 (Bremelanotide) is an FDA-approved melanocortin receptor agonist indicated for hypoactive sexual desire disorder in premenopausal women (Vyleesi). It acts on MC3 and MC4 receptors in the central nervous system to modulate sexual arousal. It is distinct from PDE5 inhibitors in its mechanism of action.

GHK-Cu is a naturally occurring tripeptide-copper complex. See the TruthTides evidence library for graded study summaries and citations.

TB-500 is a synthetic fragment of Thymosin Beta-4. See the TruthTides evidence library for graded study summaries and citations.

Selank is a synthetic heptapeptide analog of tuftsin developed in Russia. Available human trial data is limited and largely Russian-language. See the TruthTides evidence library for graded study summaries and citations.

Semax is a synthetic analog of ACTH(4-10), approved in Russia. It is not FDA-approved. See the TruthTides evidence and regulatory libraries for graded study summaries and citations.

MOTS-c is a mitochondria-derived peptide. See the TruthTides evidence library for graded study summaries and citations.

Epitalon is a synthetic tetrapeptide derived from a pineal-gland peptide. Published research is largely preclinical from a single Russian research group; human RCT data is limited. See the TruthTides evidence library for graded study summaries and citations.

Dihexa is a synthetic hexapeptide analog of angiotensin IV. See the TruthTides evidence library for graded study summaries and citations.

AOD-9604 is a modified fragment (amino acids 177-191) of human growth hormone specifically designed for fat metabolism. It stimulates lipolysis and inhibits lipogenesis without the diabetogenic effects of full-length GH. It has been studied for obesity management and cartilage repair applications.

Oral Estradiol is an FDA-approved menopausal estrogen. See the TruthTides evidence and regulatory libraries for indications, trial data, and citations.

Transdermal Estradiol is an FDA-approved menopausal estrogen delivered by patch, gel, or spray. See the TruthTides evidence and regulatory libraries for indications, comparative data, and citations.

Estradiol Valerate is an esterified estradiol used in oral and injectable hormone therapy. See the TruthTides evidence and regulatory libraries for indications and citations.

Conjugated Equine Estrogens (Premarin) are FDA-approved for menopausal hormone therapy. See the TruthTides evidence and regulatory libraries for trial data and citations.

Estriol (E3) is a weak endogenous estrogen used in low-dose vaginal preparations. See the TruthTides evidence and regulatory libraries for indications, regional availability, and citations.

Micronized Progesterone (Prometrium) is FDA-approved for endometrial protection in postmenopausal women receiving estrogen and for secondary amenorrhea. See the TruthTides evidence library for comparative data and citations.

MPA (Provera) is a synthetic progestin used for endometrial protection in combined HRT and for secondary amenorrhea. See the TruthTides evidence library for trial data and citations.

Norethindrone Acetate is a progestin used in combined oral and transdermal HRT regimens for endometrial protection. See the TruthTides evidence and regulatory libraries for indications and citations.

Dydrogesterone is a retroprogesterone used outside the US for endometrial protection in combined HRT. See the TruthTides evidence and regulatory libraries for comparative data and citations.

The Levonorgestrel intrauterine system (Mirena) provides localized progestogen for endometrial protection in women using systemic estrogen. See the TruthTides evidence and regulatory libraries for indications and citations.

Tibolone is a selective tissue estrogenic activity regulator (STEAR) used outside the US for menopausal symptoms. See the TruthTides evidence and regulatory libraries for indications and citations.

Ospemifene (Osphena) is an FDA-approved oral SERM for menopausal GSM symptoms. See the TruthTides evidence and regulatory libraries for indications and citations.

Low-dose vaginal estradiol (cream, tablet, ring) is FDA-approved for genitourinary syndrome of menopause. See the TruthTides evidence and regulatory libraries for guideline summaries and citations.

Prasterone (intravaginal DHEA) is FDA-approved for menopausal dyspareunia. See the TruthTides evidence and regulatory libraries for indications and citations.

Intramuscular Testosterone Cypionate and Enanthate are FDA-approved injectable androgens for male hypogonadism. See the TruthTides evidence and regulatory libraries for trial data and citations.

Transdermal Testosterone Gel (AndroGel, Testim, Fortesta) is FDA-approved for male hypogonadism. See the TruthTides evidence and regulatory libraries for indications, transference precautions, and citations.

Low-dose transdermal testosterone has been studied for postmenopausal HSDD. No female-specific product is FDA-approved. See the TruthTides evidence and regulatory libraries for guideline summaries and citations.

Human Chorionic Gonadotropin (hCG) is an LH-mimetic gonadotropin. It is FDA-approved for selected endocrine and fertility indications. See the TruthTides evidence and regulatory libraries for indications and citations.

Larazotide acetate is an investigational, non-FDA-approved oral octapeptide studied for intestinal permeability in celiac disease. See the TruthTides evidence library for trial summaries and citations.